bmiMD vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

bmiMD beats MEDVi overall, scoring 8/10 vs 7.7/10. bmiMD is more affordable at $119/mo vs $179/mo. Choose bmiMD for users who want an established, large-scale platform with sam. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at bmiMD and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

bmiMD

#6 of 52

8/10

Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.

Visit bmiMD

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	bmiMD	MEDVi
Our Score	8/10	7.7/10
Starting Price	$119/mo	$179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want an established, large-scale platform with same-day consults and strong promo pricing	Users who want a low entry price with oral and injectable compounded options
Ranking	#6	#20
Get started	Visit bmiMD	Visit MEDVi

Pros & Cons Compared

bmiMD

Pros

+Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
+80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
+100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
+HSA/FSA accepted for all programs

Cons

−Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
−$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
−A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

bmiMD edges out MEDVi with a score of 8/10 vs 7.7/10. If budget is your priority, bmiMD starts at $119/mo compared to MEDVi's $179/mo. Choose bmiMD if you want: users who want an established, large-scale platform with same-day consults and strong promo pricing. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither bmiMD nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review